Month: March 2022

Intrusion, Inc. Reports Fourth Quarter and Full Year 2021 Results

Written by Customer Service on March 17, 2022. Posted in Earnings Releases And Operating Results.

INTRUSION Shield Continues to Gain Traction, Resulting in Gross Margin Improvement PLANO, Texas, March 17, 2022 (GLOBE NEWSWIRE) — Intrusion Inc. (NASDAQ: INTZ), a leader in cyberattack prevention solutions, announced today financial results for the fourth quarter and full year ended December 31, 2021. Recent Financial & Business Highlights:Fourth quarter revenue of $1.6 million was flat year-over-year; full year 2021 revenue of $7.3 million was up 10% year-over-year. INTRUSION Shield revenue represented 12% of total revenue in the fourth quarter, consistent with third quarter 2021. The Company transitioned to an executive and partner led sales structure, strengthening its sales channels, and implementing processes to facilitate sales growth through premier channel partnerships. Intrusion realized operational efficiencies...

ATA Creativity Global Reports 2021 Fourth Quarter and Year-end Financial Results

Written by Customer Service on March 17, 2022. Posted in Earnings Releases And Operating Results.

Conference Call on Thursday, March 17, 2022, at 9 p.m. ET with Accompanying Investor Presentation BEIJING, March 17, 2022 (GLOBE NEWSWIRE) — ATA Creativity Global (“ACG” or the “Company”, Nasdaq: AACG), an international educational services company focused on providing quality learning experiences that cultivate and enhance students’ creativity, today announced preliminary unaudited financial results for the quarter and year ended December 31, 2021 (“Fourth Quarter 2021” and “Fiscal Year 2021”, respectively). Fiscal Year 2021 and Fourth Quarter 2021 HighlightsFiscal Year 2021 net revenues increased 24.7% to RMB202.2 million (US$31.7 million), from RMB162.2 million in the prior year Fiscal Year 2021 net loss attributable to ACG improved to RMB33.6 million (US$5.3 million), compared to RMB92.2 million in the prior year During...

Xometry Reports Fourth Quarter and Full Year 2021 Results

Written by Customer Service on March 17, 2022. Posted in Earnings Releases And Operating Results.

Strong finish to 2021: Strong quarter of accelerating revenue growth increasing 77% year-over-year. Strong gross margin trends driven by AI pricing/supplier selection and additional supplier services: Gross profit up 121% year-over-year. Strategic acquisition of Thomas: Completed the strategic acquisition of Thomas on December 9th adding 1.4 million registered buyers and ~500,000 sellers to Xometry’s rapidly growing marketplace. Expect strong growth in 2022: We expect revenue growth of 79-83% from $218.3 million to $390-400 million. Growth will be driven by increasing our active buyers and sellers, revenue synergies and expanded supplier services.ROCKVILLE, Md., March 17, 2022 (GLOBE NEWSWIRE) — Xometry, Inc. (NASDAQ:XMTR), a leading global AI enabled digital manufacturing marketplace, today reported financial results for the...

Nkarta Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Highlights

Written by Customer Service on March 17, 2022. Posted in Earnings Releases And Operating Results.

On track to announce initial Phase 1 clinical trial data from two co-lead programs in 20221H 2022 – NKX101, a CAR NK cell therapy candidate engineered with NKG2D receptor, in relapsed/refractory acute myeloid leukemia (AML) and higher-risk myelodysplastic syndrome (MDS) FY 2022 – NKX019, a CAR NK cell therapy candidate engineered with CD19 receptor, in relapsed/refractory B cell malignanciesSOUTH SAN FRANCISCO, Calif., March 17, 2022 (GLOBE NEWSWIRE) — Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat cancer, today reported financial results for the fourth quarter and year ended December 31, 2021. “2021 was a year of solid execution for Nkarta across our two clinical development programs, unique NK cell engineering platform...

Flushing Financial Corporation to Present at the Sidoti & Company Spring Small Cap Virtual Conference

Written by Customer Service on March 17, 2022. Posted in Public Companies.

UNIONDALE, N.Y., March 17, 2022 (GLOBE NEWSWIRE) — Flushing Financial Corporation (the “Company”) (Nasdaq-GS: FFIC), the parent holding company for Flushing Bank (the “Bank”), announced today that John R. Buran, President and Chief Executive Officer will be presenting at the Sidoti & Company Spring Small Cap Virtual Conference on March 23, 2022. The 30 minute presentation will begin at 10:45 am (ET) and can be accessed live at: https://sidoti.zoom.us/webinar/register/WN_lmB2mssxRSCn7ivL4xYTZg Additionally, John R. Buran and Susan K. Cullen, Senior Executive Vice President and Chief Financial Officer, will host virtual one-on-one meetings with investors on Wednesday, March 23, 2022. To register for the presentation or one-on-one meetings, visit www.sidoti.com/events. Registration is free and you don’t need to be a Sidoti client. FLUSHING...

Acutus Medical Updates Time and Date of Fourth Quarter and Full Year 2021 Financial Results

Written by Customer Service on March 17, 2022. Posted in Public Companies.

CARLSBAD, Calif., March 17, 2022 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today updated the planned release of its fourth quarter and full year 2021 financial results to March 30, 2022, as the fiscal year end 2021 audit is not yet complete and is ongoing. There is no disagreement by management with the independent auditors, and the Company fully expects to be in compliance with its SEC filing requirements. Webcast and Conference Call InformationAcutus will host a conference call to discuss the fourth quarter and full year 2021 financial results after market close on Wednesday, March 30, 2022 at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. The conference call can be accessed...

Chinook Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results

Written by Customer Service on March 17, 2022. Posted in Earnings Releases And Operating Results.

SEATTLE, March 17, 2022 (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today provided a business update and reported financial results for the fourth quarter and year ended December 31, 2021. “2021 was a very productive year for Chinook, as we initiated the phase 3 ALIGN and phase 2 AFFINITY trials for atrasentan, presented compelling phase 1/2 data in patients with IgA nephropathy for BION-1301, successfully completed IND-enabling studies for CHK-336, continued to advance multiple programs within our research pipeline and executed notable strategic partnerships including our Evotec research collaboration, formation of Sairopa B.V. for the development of non-renal assets and establishment...

Scilex Holding Company, a Majority-Owned Subsidiary of Sorrento Therapeutics, Inc., to Become Publicly Traded Through a Merger With Vickers Vantage Corp. I

Written by Customer Service on March 17, 2022. Posted in Mergers And Acquisitions.

Combined company expected to have a pro forma equity value post-money of approximately $1.64 billion, subject to potential adjustment, and with up to $140 million in expected gross proceeds before expenses, assuming no redemptions from Vickers Vantage Corp. I’s existing public shareholders, which would provide the current stockholders of Scilex an estimated ownership of approximately 88% of the outstanding shares of the Combined Company. Merger expected to close by the third quarter of 2022, and the Combined Company’s common stock is expected to be listed on Nasdaq under the new ticker symbol “SCLX” Funds will be used for, among other things, the potential registration and commercialization of SP-102 (SEMDEXA™) in 2023 and further development of the other existing non-opioid clinical programs for high unmet need acute and chronic pain...

Annual general meeting of Danske Bank 2022

Written by Customer Service on March 17, 2022. Posted in Public Companies.

Company announcement no 6 2022 Danske Bank A/SHolmens Kanal 2 – 12DK – 1092 København KTel. +45 45 14 00 00 17 March 2022Annual general meeting of Danske Bank 2022 At the annual general meeting of Danske Bank on Thursday, 17 March 2022, the general meetingadopted the Annual Report 2021 and the proposal for allocation of profits according to the adopted Annual Report 2021 re-elected Martin Blessing, Lars-Erik Brenøe, Raija-Leena Hankonen-Nybom, Bente Avnung Landsnes, Jan Thorsgaard Nielsen, and Carol Sergeant to the Board of Directors. Jacob Dahl, Allan Polack, and Helle Valentin were elected as new members of the Board of Directors, re-appointed Deloitte Statsautoriseret Revisionspartnerselskab as external auditor, adopted the Board of Directors’ proposals to amend the Articles of Association for:extension of the Board...

Verde Bio Holdings, Inc. Discusses Third Quarter Financial Results

Written by Customer Service on March 17, 2022. Posted in Public Companies.

FRISCO, TX, March 17, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Verde Bio Holdings, Inc. (OTCQB:VBHI), https://www.verdebh.com/ , a growing oil, gas and alternative energy Company, today filed its 10-Q for the three-month period November 2021 through January 2022. Mineral and Royalty income totaled $301,567. “This is a significant increase in revenue but less than the Company was expecting. Verde Bio begins receiving revenue after a transfer process, which is not in our control. While we are in pay status on the majority of our properties, some have suspended revenue during this quarter due to consolidations, which causes a month or two delay as accounting is updated,” said Scott Cox, VBHI founder and CEO. “We can count on receiving back revenues in the current quarter and year-end. “The revenue in our third quarter...

Month: March 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals